Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro de Sena Murteira Pinheiro

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
The Magic Methyl and Its Tricks in Drug Discovery and DevelopmentPedro de Sena Murteira Pinheiro, Lucas Silva Franco, Carlos Alberto Manssour Fraga
Medicinal Research Reviews|June 20, 2020
From combinations to multitarget-directed ligands: A continuum in Alzheimer's disease polypharmacologyClaudia Albertini, Alessandra Salerno, Pedro de Sena Murteira Pinheiro, et al.
Cells|September 13, 2025
HDACs in the Brain: From Chromatin Remodeling to Neurodegenerative DiseaseLuan Pereira Diniz, Pedro de Sena Murteira Pinheiro, Lucas S Franco, et al.
Expert Opinion on Drug Discovery|March 8, 2024
Molecular hybridization: a powerful tool for multitarget drug discoveryPedro de Sena Murteira Pinheiro, Lucas Silva Franco, Tadeu Lima Montagnoli, et al.
European Journal of Medicinal Chemistry|February 19, 2026
Fulfilling multiple roles in PROTAC design: The emerging potential of oligonucleotidesDaniel Alencar Rodrigues, Gustavo Salgado Pires, Urbi Roy, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Histone Deacetylases in Neurodegenerative Diseases and Their Potential Role as Therapeutic Targets: Shedding Light on AstrocytesPedro de Sena Murteira Pinheiro, Luan Pereira Diniz, Lucas S Franco, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Remapping the Chemical Space and the Pharmacological Space of Drugs: What Can We Expect from the Road Ahead?Lucas Silva Franco, Bárbara da Silva Mascarenhas de Jesus, Pedro de Sena Murteira Pinheiro, et al.
Chemical Biology & Drug Design|October 26, 2017
Structural basis for the agonist action at free fatty acid receptor 1 (FFA1R or GPR40)Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Thayssa Tavares da Silva Cunha Ferreira, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2018
N-Acylhydrazones as drugsSreekanth Thota, Daniel A Rodrigues, Pedro de Sena Murteira Pinheiro, et al.
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding GroupsGustavo Salgado Pires, Heber Victor Tolomeu, Daniel Alencar Rodrigues, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
The Magic Methyl and Its Tricks in Drug Discovery and DevelopmentPedro de Sena Murteira Pinheiro, Lucas Silva Franco, Carlos Alberto Manssour Fraga
Medicinal Research Reviews|June 20, 2020
From combinations to multitarget-directed ligands: A continuum in Alzheimer's disease polypharmacologyClaudia Albertini, Alessandra Salerno, Pedro de Sena Murteira Pinheiro, et al.
Cells|September 13, 2025
HDACs in the Brain: From Chromatin Remodeling to Neurodegenerative DiseaseLuan Pereira Diniz, Pedro de Sena Murteira Pinheiro, Lucas S Franco, et al.
Expert Opinion on Drug Discovery|March 8, 2024
Molecular hybridization: a powerful tool for multitarget drug discoveryPedro de Sena Murteira Pinheiro, Lucas Silva Franco, Tadeu Lima Montagnoli, et al.
European Journal of Medicinal Chemistry|February 19, 2026
Fulfilling multiple roles in PROTAC design: The emerging potential of oligonucleotidesDaniel Alencar Rodrigues, Gustavo Salgado Pires, Urbi Roy, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Histone Deacetylases in Neurodegenerative Diseases and Their Potential Role as Therapeutic Targets: Shedding Light on AstrocytesPedro de Sena Murteira Pinheiro, Luan Pereira Diniz, Lucas S Franco, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Remapping the Chemical Space and the Pharmacological Space of Drugs: What Can We Expect from the Road Ahead?Lucas Silva Franco, Bárbara da Silva Mascarenhas de Jesus, Pedro de Sena Murteira Pinheiro, et al.
Chemical Biology & Drug Design|October 26, 2017
Structural basis for the agonist action at free fatty acid receptor 1 (FFA1R or GPR40)Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Thayssa Tavares da Silva Cunha Ferreira, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2018
N-Acylhydrazones as drugsSreekanth Thota, Daniel A Rodrigues, Pedro de Sena Murteira Pinheiro, et al.
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding GroupsGustavo Salgado Pires, Heber Victor Tolomeu, Daniel Alencar Rodrigues, et al.
Pageof 3